PM
GMED icon

Prosight Management’s Globus Medical GMED Stock Holding History

Prosight Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,000
Closed -$1.33M – 30
2022
Q1 		$1.33M Sell
18,000
-2,188
-11% -$152K 0.86% 24
2021
Q4 		$1.46M Buy
+20,188
New +$1.47M 0.87% 25

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Prosight Management's GMED Position: Q2 2022 in Review

Prosight Management sold out of Globus Medical (GMED) in Q2 2022, closing a stake of 18,000 shares — an estimated $1.33M sold.

Prosight Management first reported a position in GMED in Q4 2021 and held it in 2 quarters. The position peaked at $1.46M in Q4 2021. 364 funds tracked by Wall St. Rank hold GMED as of Q2 2022.

  • Prosight Management reported no remaining Globus Medical position as of Q2 2022 after selling out during the quarter.
  • Prosight Management sold 18,000 Globus Medical shares in Q2 2022, an estimated $1.33M.
  • Prosight Management first reported a position in Globus Medical in Q4 2021 and held it in 2 quarters.
  • Prosight Management's Globus Medical position peaked at $1.46M in Q4 2021.
  • 364 funds tracked by Wall St. Rank held Globus Medical as of Q2 2022.

Based on Prosight Management's 13F filing for Q2 2022, filed 12 Aug 2022.